Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Hubei Jumpcan Pharmaceutical

    World Rank (Aug-2026)
    4,496
    Market Cap (Aug-2026)
    3.596 Billion USD
    World Rank (Jan-05-2024)
    3,312
    Market Cap (Jan-05-2024)
    4.298 Billion USD
    World Rank (Jul-30-2023)
    3,849
    Market Cap (Jul-30-2023)
    3.574 Billion USD
    World Rank (Dec-25-2022)
    3,642
    Market Cap (Dec-25-2022)
    3.517 Billion USD
    World Rank (Jan-07-2022)
    3,891
    Market Cap (Jan-07-2022)
    4.02 Billion USD
    Annual Revenue in USD
    1,110 Million USD
    Annual Net Income in USD
    250 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    HUBEI JUMPCAN PHARMACEUTICAL is a pharmaceutical industries company focusing on the R & D(Research and development), manufacturing and trading of Chinese traditional medicine, Western medicine, daily use chemical based on Chinese traditional medicine and Chinese medicine health products. The headquarters is in China.
  2. Hualan Biological Engineering

    World Rank (Aug-2026)
    4,518
    Market Cap (Aug-2026)
    3.577 Billion USD
    World Rank (Jan-05-2024)
    2,715
    Market Cap (Jan-05-2024)
    5.501 Billion USD
    World Rank (Jul-30-2023)
    2,567
    Market Cap (Jul-30-2023)
    5.908 Billion USD
    World Rank (Dec-25-2022)
    2,562
    Market Cap (Dec-25-2022)
    5.408 Billion USD
    World Rank (Jan-07-2022)
    2,153
    Market Cap (Jan-07-2022)
    8.42 Billion USD
    Annual Revenue in USD
    633 Million USD
    Annual Operating Income in USD
    209 Million USD
    Annual Net Income in USD
    151 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biopharmaceutical company with headquarters is in China.
  3. Laboratorios Farmaceuticos Rovi

    World Rank (Aug-2026)
    4,519
    Market Cap (Aug-2026)
    3.576 Billion USD
    World Rank (Jan-05-2024)
    3,904
    Market Cap (Jan-05-2024)
    3.477 Billion USD
    World Rank (Jul-30-2023)
    4,965
    Market Cap (Jul-30-2023)
    2.487 Billion USD
    World Rank (Dec-25-2022)
    5,494
    Market Cap (Dec-25-2022)
    1.975 Billion USD
    World Rank (Jan-07-2022)
    3,728
    Market Cap (Jan-07-2022)
    4.22 Billion USD
    Annual Revenue in USD
    715 Million USD
    Annual Net Income in USD
    169 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Laboratorios Farmaceuticos Rovi is a specialized pharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products. The company annual revenue is 419.9 million EUR, annual net income is 61 million EUR and total assets are 574.4 million EUR as on 2020. The headquarters is in Spain.
  4. Betta Pharmaceuticals

    World Rank (Aug-2026)
    4,595
    Market Cap (Aug-2026)
    3.486 Billion USD
    World Rank (Jan-05-2024)
    4,431
    Market Cap (Jan-05-2024)
    2.948 Billion USD
    World Rank (Jul-30-2023)
    4,045
    Market Cap (Jul-30-2023)
    3.333 Billion USD
    World Rank (Dec-25-2022)
    4,195
    Market Cap (Dec-25-2022)
    2.891 Billion USD
    World Rank (Jan-07-2022)
    3,256
    Market Cap (Jan-07-2022)
    5.06 Billion USD
    Annual Revenue in USD
    352 Million USD
    Annual Net Income in USD
    60 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Betta Pharmaceuticals is a senior executive team for innovative drug discovery and commercialization company mainly forced on drug development for cancer, diabetes and other major diseases that seriously affect human health. It is having more than 30 innovative drug projects in Betta’s pipeline with 15 in clinical stages, including 4 in phase III clinical trials. The company annual revenue is 284.1 million USD and 1,466 employee as on 2020. The headquarters is in China.
  5. Apeloa Pharmaceutical

    World Rank (Aug-2026)
    4,611
    Market Cap (Aug-2026)
    3.470 Billion USD
    World Rank (Jan-05-2024)
    4,966
    Market Cap (Jan-05-2024)
    2.494 Billion USD
    World Rank (Jul-30-2023)
    4,464
    Market Cap (Jul-30-2023)
    2.905 Billion USD
    World Rank (Dec-25-2022)
    3,657
    Market Cap (Dec-25-2022)
    3.489 Billion USD
    World Rank (Jan-07-2022)
    2,851
    Market Cap (Jan-07-2022)
    5.94 Billion USD
    Annual Revenue in USD
    1,404 Million USD
    Annual Net Income in USD
    150 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Apeloa Pharmaceutical is a engaged in the research and development, production and sales of pharmaceutical products company. The products are mainly concentrated in cardio cerebrovascular, anti infection, anti tumor and other treatment areas. The headquarters is in China.
    Facts About Company
    Apeloa Pharmaceutical company annual revenue was 10.5 billion CNY and annual net income was 989 million CNY for year ending Dec-2022.
  6. Virbac SA

    World Rank (Aug-2026)
    4,681
    Market Cap (Aug-2026)
    3.378 Billion USD
    World Rank (Jan-05-2024)
    4,084
    Market Cap (Jan-05-2024)
    3.289 Billion USD
    World Rank (Jul-30-2023)
    4,479
    Market Cap (Jul-30-2023)
    2.889 Billion USD
    World Rank (Dec-25-2022)
    5,356
    Market Cap (Dec-25-2022)
    2.050 Billion USD
    World Rank (Jan-07-2022)
    4,067
    Market Cap (Jan-07-2022)
    3.80 Billion USD
    Annual Revenue in USD
    1,341 Million USD
    Annual Operating Income in USD
    201 Million USD
    Annual Net Income in USD
    133 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    VIRBAC SA is animal healthcare medicine manufacturing and animal feed producing company. Headquarters is in France.

    Virbac offers veterinarians, farmers and pet owners in more than 100 countries a comprehensive and practical range of products and services that improves health of animals.

  7. uniQure N.V.

    World Rank (Aug-2026)
    4,693
    Market Cap (Aug-2026)
    3.373 Billion USD
    World Rank (Jan-05-2024)
    15,314
    Market Cap (Jan-05-2024)
    0.324 Billion USD
    World Rank (Jul-30-2023)
    13,144
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    7,966
    Market Cap (Dec-25-2022)
    1.090 Billion USD
    World Rank (Jan-07-2022)
    9,983
    Market Cap (Jan-07-2022)
    0.90 Billion USD
    Annual Revenue in USD
    524 Million USD
    Annual Net Income in USD
    329 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in Amsterdam, Netherlands.
  8. Harbin High-Tech (Group)

    World Rank (Aug-2026)
    4,701
    Market Cap (Aug-2026)
    3.365 Billion USD
    World Rank (Jan-05-2024)
    4,436
    Market Cap (Jan-05-2024)
    2.943 Billion USD
    World Rank (Jul-30-2023)
    3,825
    Market Cap (Jul-30-2023)
    3.608 Billion USD
    World Rank (Dec-25-2022)
    3,924
    Market Cap (Dec-25-2022)
    3.179 Billion USD
    World Rank (Jan-07-2022)
    3,612
    Market Cap (Jan-07-2022)
    4.41 Billion USD
    Annual Revenue in USD
    231 Million USD
    Annual Net Income in USD
    53 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  9. Guangdong Zhongsheng Pharmaceutical

    World Rank (Aug-2026)
    4,731
    Market Cap (Aug-2026)
    3.317 Billion USD
    World Rank (Jan-05-2024)
    5,896
    Market Cap (Jan-05-2024)
    1.888 Billion USD
    World Rank (Jul-30-2023)
    5,827
    Market Cap (Jul-30-2023)
    1.956 Billion USD
    World Rank (Dec-25-2022)
    3,155
    Market Cap (Dec-25-2022)
    4.208 Billion USD
    World Rank (Jan-07-2022)
    7,590
    Market Cap (Jan-07-2022)
    1.45 Billion USD
    Headquarters Country
  10. Cosmos Pharmaceutical Corporation

    World Rank (Aug-2026)
    4,758
    Market Cap (Aug-2026)
    3.291 Billion USD
    World Rank (Jan-05-2024)
    3,269
    Market Cap (Jan-05-2024)
    4.361 Billion USD
    World Rank (Jul-30-2023)
    3,204
    Market Cap (Jul-30-2023)
    4.578 Billion USD
    World Rank (Dec-25-2022)
    3,149
    Market Cap (Dec-25-2022)
    4.220 Billion USD
    World Rank (Jan-07-2022)
    2,987
    Market Cap (Jan-07-2022)
    5.62 Billion USD
    Annual Revenue in USD
    5,512 Million USD
    Annual Net Income in USD
    169 Million USD
    Annual Results for Period Ending
    MAY-2022 ending year
    Headquarters Country
    Company Profile

    Cosmo Pharmaceutical is a pharmaceutical company with a specialized focus on gastroenterology and endoscopy.

    Headquarters is in Japan.

    Cosmo Pharmaceutical has 234 employees as on December 2019.

    As on 2019, Annual Revenues is 62.49 Million EUR and Net Loss after taxes is 24.49 Million EUR.

    As on Mar-2022, COSMOS PHARMACEUTICAL CORPORATION has 1,244 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions.

Share

Ads